2m 2m 2m 2m 2m 2m 2m
TSCAN THERAPEUT (TCRX)
NASDAQ
$0.22-$0.008 (-3.57%)
Price as of Oct 22, 2026 7:38 PM EDT- $14.2MMarket Cap
- -90.00%1-Year Change
- BiotechnologyIndustry
TSCAN THERAPEUT (TCRX)
$0.22-$0.008 (-3.57%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
LYNX1 CAPITAL MANAGEMENT LP | 12.63% | 8.0M | 0 (0.00%) | Jun 30, 2026 |
BVF INC/IL | 8.76% | 5.6M | 0 (0.00%) | Jun 30, 2026 |
BLACKROCK FUNDING, INC. /DE | 7.81% | 5.0M | +328,824 (+6.63%) | Dec 31, 2024 |
BLACKROCK INC. | 7.03% | 4.5M | +2.8M (+61.92%) | Jun 30, 2024 |
BAKER BROS. ADVISORS LP | 4.39% | 2.8M | 0 (0.00%) | Jun 30, 2026 |
VANGUARD GROUP INC | 3.90% | 2.5M | +157,817 (+6.37%) | Dec 31, 2025 |
VANGUARD CAPITAL MANAGEMENT LLC | 3.40% | 2.2M | +4,575 (+0.21%) | Jun 30, 2026 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
VANGUARD INDEX FUNDS | 3.27% | 2.1M | -2,015 (-0.10%) | Jun 30, 2026 |
BlackRock Health Sciences Trust II | 0.64% | 405,905 | -1,105 (-0.27%) | Jun 30, 2026 |
NATIONWIDE VARIABLE INSURANCE TRUST | 0.13% | 83,500 | +21,300 (+25.51%) | Jun 30, 2026 |
BRIDGEWAY FUNDS INC | 0.11% | 70,400 | -35,000 (-49.72%) | Jun 30, 2026 |
GuideStone Funds | 0.10% | 65,813 | +26,313 (+39.98%) | Jun 30, 2026 |
Fidelity Rutland Square Trust II | 0.05% | 29,612 | +28,412 (+95.95%) | May 31, 2026 |
VANGUARD INSTITUTIONAL INDEX FUNDS | 0.05% | 29,605 | 0 (0.00%) | Jun 30, 2026 |
Current Ownership Distribution
- Institutions522.6M (85.36%)
- Mutual Funds71.5M (11.68%)
- Insiders18.1M (2.96%)
- Other0 (0.00%)
Insider Transactions
- 2.96% (18.1M)Current InsiderOwnership (%, shares)
- 1Number of InsiderBuying (last 12 months)
- $21.4MAmount of InsiderBuying (last 12 months)
- 0Number of InsiderSelling (last 12 months)
- $0.00Amount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
ZDRAVESKI ZORAN See Remarks | Award | Oct 01, 2026 | $0.00 | 300,000 | $0.00 | 304,716 |
MacBeath Gavin Chief Executive Officer | Award | Jan 20, 2026 | $0.00 | 1.2M | $0.00 | 1.2M |
Amello Jason Chief Financial Officer | Award | Jan 20, 2026 | $0.00 | 350,000 | $0.00 | 350,000 |
ZDRAVESKI ZORAN See Remarks | Award | Jan 20, 2026 | $0.00 | 350,000 | $0.00 | 350,000 |
Louis Chrystal Chief Medical Officer | Award | Jan 20, 2026 | $0.00 | 420,000 | $0.00 | 420,000 |
Dworak Leiden See Remarks | Award | Jan 20, 2026 | $0.00 | 100,000 | $0.00 | 100,000 |
Lynx1 Capital Management LP | Buy | Dec 23, 2025 | $5,601.94 | 6,232 | $0.90 | 8.0M |
Lynx1 Capital Management LP | Buy | Dec 22, 2025 | $67,950.00 | 75,500 | $0.90 | 8.0M |
Lynx1 Capital Management LP | Buy | Dec 19, 2025 | $71,974.02 | 80,069 | $0.90 | 7.9M |
Nicholson Garry A | Award | Jun 30, 2025 | $0.00 | 67,000 | $0.00 | 67,000 |
Woods Keith | Award | Jun 30, 2025 | $0.00 | 67,000 | $0.00 | 67,000 |
Gruia Gabriela | Award | Jun 30, 2025 | $0.00 | 67,000 | $0.00 | 67,000 |
Klencke Barbara | Award | Jun 30, 2025 | $0.00 | 67,000 | $0.00 | 67,000 |
BAKER BROS. ADVISORS LP | Award | Jun 30, 2025 | $0.00 | 67,000 | $0.00 | 67,000 |
Dorton Katina | Award | Jun 30, 2025 | $0.00 | 67,000 | $0.00 | 67,000 |
BAKER BROS. ADVISORS LP | Award | Jun 30, 2025 | $0.00 | 67,000 | $0.00 | 67,000 |
ZDRAVESKI ZORAN See Remarks | Award | Jan 03, 2025 | $0.00 | 250,000 | $0.00 | 250,000 |
Amello Jason Chief Financial Officer | Award | Jan 03, 2025 | $0.00 | 270,000 | $0.00 | 270,000 |
Louis Chrystal Chief Medical Officer | Award | Jan 03, 2025 | $0.00 | 400,000 | $0.00 | 400,000 |
MacBeath Gavin Chief Executive Officer | Award | Jan 03, 2025 | $0.00 | 800,000 | $0.00 | 800,000 |
Lynx1 Capital Management LP | Buy | Dec 26, 2024 | $30.0M | 7.5M | $4.00 | 7.5M |
Lynx1 Capital Management LP | Buy | Dec 13, 2024 | $290,140.00 | 100,000 | $2.90 | 5.4M |
Lynx1 Capital Management LP | Buy | Dec 12, 2024 | $95,628.96 | 31,800 | $3.01 | 5.3M |